GAD1 and encephalitis: For GAD encephalitis in particular this may be important, because GAD antibodies occur at 1% of healthy people and in 80% of those with type 1 diabetes; there is not yet convincing evidence that GAD antibodies are pathogenic, rather than an epiphenomenon [9].